Veraxa Biotech AG Ordinary Shares
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-06-30 | 2024-12-31 |
|---|---|---|---|
Cash | 1,613 | 3,315 | 5,362 |
Basic Shares | 141,407 | 141,407 | 141,407 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $23 | $0 | $0 |
Gross Profit | 15 | 0 | |
EBITDA | -64,905 | -26,876 | -15,805 |
EBIT | -67,003 | -28,753 | -17,655 |
Net Income | -66,613 | -28,132 | -16,544 |
Net Change In Cash | 23 | 0 | 0 |
Free Cash Flow | -10,339 | -7,841 | -7,500 |
Cash | 1,613 | 5,362 | 11,352 |
Basic Shares | 141,407 | 141,407 | 141,407 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0.006 |
2025-12-31 | $0.05 |
2025-09-30 | $0.07 |
2025-06-30 | $0.07 |